The PKR activator PACT is induced by Aβ: Involvement in Alzheimer's disease

Brain Pathology

Volumn 22, Issue 2, 2012, Pages 219-229

  Paquet, Claire ^a,b,c   Mouton Liger, François ^b,c   Meurs, Eliane F ^d   Mazot, Pierre ^c   Bouras, Constantin ^e   Pradier, Laurent ^f   Gray, Françoise ^b   Hugon, Jacques ^a,b,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT DU FER À MOULIN   (France)

^d INSTITUT PASTEUR   (France)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f SANOFI   (France)

Author keywords

Alzheimer's disease; beta amyloid; neuronal death; PACT; PKR

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; PROTEIN KINASE R; PROTEIN KINASE R ACTIVATING PROTEIN; TAU PROTEIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE, TUMOR; EIF-2 KINASE; ENZYME INDUCTION; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; PHOSPHORYLATION; RNA-BINDING PROTEINS; TAU PROTEINS;

EID: 84857646036     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00520.x     Document Type: Article

References (33)

1. Abdelrahim M, Liu S, Safe S, (2005) Induction of endoplasmic reticulum-induced stress genes in Panc-1 pancreatic cancer cells is dependent on Sp proteins. J Biol Chem 280: 16508-16513.
2. Bennett RL, Blalock WL, May WS, (2004) Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition. J Biol Chem 279: 42687-42693.
3. Bose A, Mouton-Liger F, Paquet C, Mazot P, Vigny M, Gray F, Hugon J, (2011) Modulation of Tau Phosphorylation by the Kinase PKR: implications in Alzheimer's disease. Brain Pathol 21: 189-200.
4. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, et al, (2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165: 1289-1300.
5. Chang RC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J, (2002) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 83: 1215-1225.
6. Chang RC, Wong AK, Ng HK, Hugon J, (2002) Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13: 2429-2432.
7. Citron BA, Dennis JS, Zeitlin RS, Echeverria V, (2008) Transcription factor Sp1 dysregulation in Alzheimer's disease. J Neurosci Res 86: 2499-2504.
8. Costa RO, Ferreiro E, Cardoso SM, Oliveira CR, Pereira CM, (2010) ER stress-mediated apoptotic pathway induced by Abeta peptide requires the presence of functional mitochondria. J Alzheimers Dis 20: 625-636.
9. Daher A, Laraki G, Singh M, Melendez-Pena CE, Bannwarth S, Peters AH, et al, (2009) TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol Cell Biol 29: 254-265.
10. Der SD, Yang YL, Weissmann C, Williams BR, (1997) A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A 94: 3279-3283.
11. Duyckaerts C, Delatour B, Potier MC, (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118: 5-36.
12. Fasciano S, Kaufman A, Patel RC, (2007) Expression of PACT is regulated by Sp1 transcription factor. Gene 388: 74-82.
13. Garcia MA, Meurs EF, Esteban M, (2007) The dsRNA protein kinase PKR: virus and cell control. Biochimie 89: 799-811.
14. Hardy JA, Higgins GA, (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
15. Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, Scheper W, (2005) The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol 110: 165-172.
16. Ito T, Yang M, May WS, (1999) RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J Biol Chem 274: 15427-15432.
17. Lee ES, Yoon CH, Kim YS, Bae YS, (2007) The double-strand RNA-dependent protein kinase PKR plays a significant role in a sustained ER stress-induced apoptosis. FEBS Lett 581: 4325-4332.
18. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN, (2006) The role of PACT in the RNA silencing pathway. EMBO J 25: 522-532.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
20. Nekhai S, Bottaro DP, Woldehawariat G, Spellerberg A, Petryshyn R, (2000) A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation. Peptides 21: 1449-1456.
21. Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, et al, (2006) Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139: 1343-1354.
22. Patel CV, Handy I, Goldsmith T, Patel RC, (2000) PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 275: 37993-37998.
23. Patel RC, Sen GC, (1998) PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 17: 4379-4390.
24. Peters GA, Li S, Sen GC, (2006) Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis. J Biol Chem 281: 35129-35136.
25. Peters GA, Dickerman B, Sen GC, (2009) Biochemical analysis of PKR activation by PACT. Biochemistry 48: 7441-7447.
26. Peters GA, Seachrist DD, Keri RA, Sen GC, (2009) The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc Natl Acad Sci U S A 106: 10696-10701.
27. Proud CG, (1995) PKR: a new name and new roles. Trends Biochem Sci 20: 241-246.
28. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
29. Santpere G, Nieto M, Puig B, Ferrer I, (2006) Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies. Neurosci Lett 397: 30-34.
30. Singh M, Fowlkes V, Handy I, Patel CV, Patel RC, (2009) Essential role of PACT-mediated PKR activation in tunicamycin-induced apoptosis. J Mol Biol 385: 457-468.
31. Sultana R, Perluigi M, Butterfield DA, (2009) Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol 118: 131-150.
32. Wang X, Fan Z, Wang B, Luo J, Ke ZJ, (2007) Activation of double-stranded RNA-activated protein kinase by mild impairment of oxidative metabolism in neurons. J Neurochem 103: 2380-2390.
33. Williams BR, (1997) Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc Trans 25: 509-513.